Support Alert

Drug Safety update: Quinine: reminder of dose-dependent QT-prolonging effects; updated medicine interactions

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update for Quinine. Quinine has dose-dependent QT-interval-prolonging effects and should be used with caution in patients with risk factors for QT prolongation or in those with atrioventricular block.

Further details of the safety update, advice and recommendations are available on the MHRA website.